261 related articles for article (PubMed ID: 26036452)
1. Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression.
Duval F; Mokrani MC; Erb A; Gonzalez Lopera F; Alexa C; Proudnikova X; Butucaru I
Psychoneuroendocrinology; 2015 Sep; 59():71-80. PubMed ID: 26036452
[TBL] [Abstract][Full Text] [Related]
2. Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients.
Duval F; Mokrani MC; Erb A; Gonzalez Opera F; Calleja C; Paris V
Psychoneuroendocrinology; 2017 Nov; 85():100-109. PubMed ID: 28843902
[TBL] [Abstract][Full Text] [Related]
3. Are the thyroid and adrenal system alterations linked in depression?
Mokrani MC; Duval F; Erb A; Gonzalez Lopera F; Danila V
Psychoneuroendocrinology; 2020 Dec; 122():104831. PubMed ID: 33068950
[TBL] [Abstract][Full Text] [Related]
4. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
5. Thyroid axis activity and serotonin function in major depressive episode.
Duval F; Mokrani MC; Bailey P; Correa H; Diep TS; Crocq MA; Macher JP
Psychoneuroendocrinology; 1999 Oct; 24(7):695-712. PubMed ID: 10451906
[TBL] [Abstract][Full Text] [Related]
6. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
[TBL] [Abstract][Full Text] [Related]
7. Thyroid axis activity and suicidal behavior in depressed patients.
Duval F; Mokrani MC; Lopera FG; Diep TS; Rabia H; Fattah S
Psychoneuroendocrinology; 2010 Aug; 35(7):1045-54. PubMed ID: 20129737
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
[TBL] [Abstract][Full Text] [Related]
9. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.
Baek JH; Kang ES; Fava M; Mischoulon D; Nierenberg AA; Lee D; Heo JY; Jeon HJ
J Affect Disord; 2014 Dec; 169():112-7. PubMed ID: 25189990
[TBL] [Abstract][Full Text] [Related]
10. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
Tokgöz B; Utaş C; Doğukan A; Oymak O; Keleştimur F
Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
[TBL] [Abstract][Full Text] [Related]
11. Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder.
Staner L; Duval F; Calvi-Gries F; Mokrani MC; Bailey P; Hode Y; Toussaint M; Luthringer R; Muzet A; Macher JP
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):535-47. PubMed ID: 11370996
[TBL] [Abstract][Full Text] [Related]
12. The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.
Schüle C; Baghai TC; Alajbegovic L; Schwarz M; Zwanzger P; Eser D; Schaaf L; Möller HJ; Rupprecht R
Eur Arch Psychiatry Clin Neurosci; 2005 Oct; 255(5):334-40. PubMed ID: 15747035
[TBL] [Abstract][Full Text] [Related]
13. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression.
Bschor T; Baethge C; Adli M; Lewitzka U; Eichmann U; Bauer M
J Psychiatry Neurosci; 2003 May; 28(3):210-6. PubMed ID: 12790161
[TBL] [Abstract][Full Text] [Related]
15. Thyroid axis activity and dopamine function in depression.
Duval F; Mokrani MC; Erb A; Danila V; Lopera FG; Foucher JR; Jeanjean LC
Psychoneuroendocrinology; 2021 Jun; 128():105219. PubMed ID: 33839430
[TBL] [Abstract][Full Text] [Related]
16. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
Tsuru J; Ishitobi Y; Ninomiya T; Kanehisa M; Imanaga J; Inoue A; Okamoto S; Maruyama Y; Higuma H; Tanaka Y; Hanada H; Isogawa K; Akiyoshi J
Neuro Endocrinol Lett; 2013; 34(5):409-17. PubMed ID: 23922049
[TBL] [Abstract][Full Text] [Related]
17. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
[TBL] [Abstract][Full Text] [Related]
18. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
Hikichi T; Akiyoshi J; Ichioka S; Tanaka Y; Tsuru J; Goto S; Matsushita H; Hanada H; Isogawa K; Nagayama H
Neuropsychobiology; 2007; 55(1):21-7. PubMed ID: 17556849
[TBL] [Abstract][Full Text] [Related]
19. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
Duval F; Mokrani MC; Monreal-Ortiz JA; Fattah S; Champeval C; Schulz P; Macher JP
Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179
[TBL] [Abstract][Full Text] [Related]
20. An acute injection of corticosterone increases thyrotrophin-releasing hormone expression in the paraventricular nucleus of the hypothalamus but interferes with the rapid hypothalamus pituitary thyroid axis response to cold in male rats.
Sotelo-Rivera I; Jaimes-Hoy L; Cote-Vélez A; Espinoza-Ayala C; Charli JL; Joseph-Bravo P
J Neuroendocrinol; 2014 Dec; 26(12):861-9. PubMed ID: 25283355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
